A Short Series of Laparoscopic Mesenteric Bypasses for Chronic Mesenteric Ischemia
Open Access
- 1 March 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in Vascular Health and Risk Management
- Vol. ume 16, 87-97
- https://doi.org/10.2147/VHRM.S243264
Abstract
Background: Laparoscopic aortomesenteric bypass may be performed to treat the chronic mesenteric ischemia patients who are not suitable for endovascular treatment. This study presents an initial experience with a limited series of laparoscopic mesenteric artery revascularization for the treatment of mesenteric ischemia. Methods: Chronic mesenteric ischemia (CMI) patients with previous unsuccessful endovascular treatment or with arterial occlusion and extensive calcification precluding safe endovascular treatment were offered laparoscopic mesenteric revascularization. From October 2015 until November 2018, nine patients with CMI underwent laparoscopic revascularization. In addition to demographic data and perioperative results of the treatment, graft patency was assessed with Duplex ultrasound at 1, 3, 6 and 12 months, and annually thereafter. A descriptive analysis of the data was performed. Results: All bypasses were constructed with an 8 mm ring enforced expanded polytetrafluoroethylene graft in a retrograde fashion (from infrarenal aorta or iliac artery) to either superior mesenteric artery or splenic artery (2 cases). Median operation time was 356 mins (range 247– 492 mins). Five patients had a history of unsuccessful endovascular treatment. Laparoscopic technical success was 78%, and the primary open conversion rate was 22%. All laparoscopic revascularization procedures remained patent after discharge during a median follow-up time of 26 months (range 18– 49 months). The primary graft patency at 30 days was 78%. Primary assisted, and secondary graft patency was 78% and 100%, respectively. Median weight gain was 2 kg (range 2– 18 kg), and all patients achieved relief from postprandial pain and nausea. No mortality was observed during the follow-up period. Conclusion: Laparoscopic aortomesenteric revascularization procedures for chronic mesenteric ischemia are feasible but require careful patient selection. These procedures should only be performed at referral centers by vascular surgeons with prior experience in laparoscopic vascular surgery.Keywords
This publication has 21 references indexed in Scilit:
- Chronic Mesenteric Ischemia: 20 Year Experience of Open Surgical TreatmentEuropean Journal of Vascular and Endovascular Surgery, 2015
- Open abdominal surgery: a risk factor for future laparoscopic surgery?The American Journal of Surgery, 2015
- Hostile Abdomen Index Risk Stratification and Laparoscopic ComplicationsJSLS : Journal of the Society of Laparoendoscopic Surgeons, 2014
- Mesenteric revascularization: management and outcomes in the United States, 1988-2006Journal of Vascular Surgery, 2009
- Open versus endovascular revascularization for chronic mesenteric ischemia: Risk-stratified outcomesJournal of Vascular Surgery, 2009
- Totally Laparoscopic Aortohepatic Bypass for Aortic Debranching During Endovascular Thoracoabdominal Aneurysm RepairEuropean Journal of Vascular and Endovascular Surgery, 2007
- ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)Circulation, 2006
- Total laparoscopic bypass for aortoiliac occlusive lesions: 93-case experienceJournal of Vascular Surgery, 2004
- THE CLINICAL SPECTRUM OF PENETRATING INJURY TO THE SUPERIOR MESENTERIC ARTERIAL CIRCULATIONThe Journal of Trauma and Acute Care Surgery, 1972
- Acute and Chronic Thrombosis of the Mesenteric Arteries Associated with MalabsorptionThe New England Journal of Medicine, 1958